2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Genomics, technology, bioinformatics<br />
probes while retaining or improving the predictive power . Validation<br />
<strong>of</strong> the model was performed using 10-fold cross-validation regime to<br />
avoid overfitting and assure statistical validity <strong>of</strong> results. The predictive<br />
model was evaluated on the basis <strong>of</strong> three performance measures:<br />
sensitivity, specificity, and the area under the receiver operating characteristics<br />
curve (Table 1). Proposed model confirm the known and<br />
indicate some novel patterns which may contribute to a better understanding<br />
<strong>of</strong> SMA .<br />
Table 1 . Performance measures .<br />
Model<br />
Full Stepwise<br />
SMA I SMA II SMA III SMA I SMA II SMA III<br />
Sensitivity 0 .471 0 .679 0 .700 0 .571 0 .719 0 .737<br />
Specificity 0 .896 0 .676 0 .844 0 .902 0 .758 0 .848<br />
AUC 0 .772 0 .676 0 .707 0 .748 0 .746 0 .771<br />
P08.73<br />
smRt arrays as a high resolution technique for detection <strong>of</strong> DNA<br />
microvariations<br />
P. Armero, C. Maqueda, A. Hernández, S. Esteban, P. Madero;<br />
Centro de Análisis Genéticos, Zaragoza, Spain.<br />
Introduction: Nowadays, array CGH is one <strong>of</strong> the highest resolution<br />
techniques for genome-wide detection <strong>of</strong> chromosomal alterations .<br />
Genome screening using array CGH has great potential in the characterization<br />
<strong>of</strong> numerous unexplained chromosomal aberrations . The<br />
whole genome Sub-Megabase Resolution Tiling Array (SMRT array)<br />
is capable <strong>of</strong> identifying microamplifications and microdeletions at a<br />
resolution <strong>of</strong> 100 Kb .<br />
The aim <strong>of</strong> this study was to show the utility <strong>of</strong> this SMRT arrays to<br />
provide precise information about the size and breakpoints <strong>of</strong> DNA<br />
copy number gains and losses .<br />
Methods: We present a patient with microcephaly, epilepsy and mental<br />
retardation, with a female normal karyotipe 46, XX . A SMRT array,<br />
(from Wan Lam Laboratory at the BC Cancer Research Centre) analysis<br />
was performed . Moreover, two MLPA kits (SALSA P096 and SAL-<br />
SA, from MRC-Holland) and fluorescent in situ hybridization (FISH)<br />
technique were carried out .<br />
Results: The SMRT array analysis showed a 4p subtelomeric deletion<br />
<strong>of</strong> 1.25 Mb. MLPA study <strong>of</strong> the specific 4p16.3 subtelomeric region<br />
confirmed this microdeletion. Five <strong>of</strong> the sixteen specific probes <strong>of</strong><br />
MLPA kit, located in the new defined WHSCR-2, were deleted. FISH<br />
assays showed a deleted pattern with the 4p subtelomeric probe but<br />
normal results were obtained when hybridization was performed with<br />
specific WHS probe.<br />
Conclusions: The SMRT array study confirms the small deletion WH-<br />
SCR-2 previously detected by MLPA and not detected by WHS FISH .<br />
SMRT array arises as an effective technique to detect DNA microvariations<br />
and provides more information about their size and precise<br />
breakpoints .<br />
P08.74<br />
Flexible and 640-multiplex array detection <strong>of</strong> nucleic acid<br />
variations<br />
K. Krjutskov 1 , R. Andreson 1 , R. Mägi 1 , A. Khrunin 2 , A. Metspalu 1 ;<br />
1 IMCB, Tartu, Estonia, 2 IMG RAS, Moscow, Russian Federation.<br />
DNA sequence variation detection is important in various biomedical<br />
applications such as gene identification <strong>of</strong> common diseases, disease<br />
diagnosis and -treatment, drug discovery and forensic analysis . Here,<br />
we describe an arrayed primer extension-based genotyping method<br />
(APEX-2) that allows multiplex DNA amplification (640-plex) and<br />
detection <strong>of</strong> single nucleotide polymorphism (SNP) or mutations on<br />
microarray through four-color single-base extension . The principle <strong>of</strong><br />
multiplex PCR needs two oligonucleotides per SNP/mutation generating<br />
amplicons that contain the unknown base pair (studied position) .<br />
The same oligonucleotides are used in the following step as attached<br />
single-base extension primers on a microarray . The call rate <strong>of</strong> 640plex<br />
APEX-2 was 99 .87%, the reproducibility was 99 .92% and the coincidence<br />
between Illumina <strong>Human</strong>CNV370-Duo v1.0 BeadChips and<br />
APEX-2 genotyping was 98 .6% . The method described here may be<br />
very useful for a custom number <strong>of</strong> SNP- or mutation detection analysis,<br />
molecular diagnostics and in forensic analysis . APEX-2 has also<br />
the potential to fill the gap (up to 1500 positions) between expensive<br />
high-density platforms and low-multiplex level detection systems .<br />
P08.75<br />
Transplantation <strong>of</strong> amniotic fluid-derived stem cells in a rodent<br />
model <strong>of</strong> stroke<br />
I. Antonucci 1,2 , M. Maki 3,4 , S. Yu 3,4 , T. Masuda 3,4 , M. M. Ali 3,4 , D. C. Hess 3,4 , G.<br />
Palka 1 , L. Stuppia 1,2 , C. V. Borlongan 3,4 ;<br />
1 G. D’Annunzio University Foundation, Chieti, Italy, 2 Aging Research Center,<br />
CESI, Chieti, Italy, 3 Department <strong>of</strong> Neurology, Medical College <strong>of</strong> Georgia,<br />
Augusta, GA, United States, 4 Research and Affiliations Service Line, Augusta<br />
Veterans Affairs Medical Center, Augusta, GA, United States.<br />
The discovery <strong>of</strong> amniotic fluid (AF) -derived stem cells initiated a new<br />
and very promising field in stem cell research. These cells possess<br />
immune-privileged characteristics suitable for a successful transplantation<br />
. The purpose <strong>of</strong> this study was to reveal stemness <strong>of</strong> rat AF-derived<br />
cells and to test the effectiveness <strong>of</strong> transplantation <strong>of</strong> fresh as<br />
compared to cultured AF cells in a rodent model <strong>of</strong> stroke . Cells were<br />
characterized at day 25 <strong>of</strong> culture by immunohistochemical analysis to<br />
highlight the presence <strong>of</strong> embryonic stem cell markers . This analysis<br />
showed that cultured, i .e ., adherent AFcells resembled a mesenchymal-like<br />
morphology and were positive for OCT4 and SSEA, typical<br />
embryonic stem cell markers . A parallel in vivo study subjected rats<br />
to middle cerebral artery (MCA) occlusion for 60 minutes and subsequently<br />
assigned to one <strong>of</strong> the following intravenous transplantation:<br />
i) freshly isolated AF cells; ii) cultured rat AF mesenchymal-like stem<br />
cells; iii) vehicle . Behavioral tests were performed prior to stroke surgery<br />
and repeated at day 2 post-stroke/post-transplantation to evaluate<br />
the functional consequences <strong>of</strong> the MCA occlusion and to quantify<br />
improvements in motor and cognitive function after transplantation .<br />
Transplantation <strong>of</strong> cultured, but not freshly isolated AF mesenchymallike<br />
stem cells promoted significant recovery from stroke-induced motor<br />
and neurologic deficits compared to vehicle-infused stroke animals.<br />
The present study shows that cultured rat AF-derived cells are more<br />
therapeutically active than freshly isolated cells . The observed behavioral<br />
benefits demonstrate that AF stand as a highly potent alternative<br />
source <strong>of</strong> stem cells for therapeutic strategies in stroke and related<br />
neurological disorders .<br />
P08.76<br />
e-infrastructure for thalassaemia research network (ithanet)<br />
M. Kleanthous;<br />
The Institute <strong>of</strong> Neurology and <strong>Genetics</strong>, Nicosia, Cyprus.<br />
The main objective <strong>of</strong> Ithanet (http://www.ithanet.eu) is to enhance the<br />
scientific potential <strong>of</strong> the haemoglobinopathies’ research community<br />
using infrastructures and tools <strong>of</strong> <strong>European</strong> research networks . Ithanet<br />
aims to harmonise and develop these resources for the coordination <strong>of</strong><br />
existing research activities as a base for future collaborative projects .<br />
The consortium comprises <strong>of</strong> all major <strong>European</strong> research institutions<br />
active in the field and a number <strong>of</strong> collaborating partner institutions<br />
from non-EU Mediterranean and Black-Sea countries . In total Ithanet<br />
associates 26 partners from 16 countries . In order to set-up and maintain<br />
interaction between the partners involved as well as to coordinate<br />
training and project management activities, Ithanet utilizes teleconferencing<br />
technology . Additionally Ithanet introduced media broadcasting<br />
and streaming technologies for conferences and teaching courses on<br />
haemoglobinopathies, contributing to the exchange and dissemination<br />
<strong>of</strong> good practices in the field <strong>of</strong> e-learning.Aiming to encourage a high<br />
level <strong>of</strong> interaction among members <strong>of</strong> the haemoglobinopathy community,<br />
a dedicated portal has been created (http://portal/ithanet.eu) .<br />
Visitors to the Ithanet portal can quickly exchange information, share<br />
ideas, enhance the global awareness <strong>of</strong> pertinent issues, and help define<br />
critical areas <strong>of</strong> haemoglobinopathy treatment and research. The<br />
portal <strong>of</strong>fers the latest news, techniques and information on haemoglobinopathies<br />
and also serves as a platform for the easy exchange <strong>of</strong> information<br />
and dialogues between interested groups, both patients and<br />
researchers . The portal is also used as a database <strong>of</strong> standard scientific<br />
protocols, methodologies, and repositories. It contains information<br />
on almost all Thalassaemia-related institutions and medical centres as<br />
well as patient and scientific societies.